Our results indicated that serum levels of glucose, insulin as well as liver glycogen content, TG and VLDL-c were significantly increased in high source group (HS group) compared to control group (p < 0.05). A significant decline was observed in blood glucose and FIRI (p < 0.05) in TP-treated groups compared to HS group. The observed effect, at 100 and 200 mg/Kg, was more obvious than the 50 mg/Kg groups (
Table 1). On the other hand, FIRI was increased in HS group compared to the TP-treated groups. However, leptin levels tend to increase in HS group but did not changed significantly in comparison with the control group. TP-EAE administration at doses of 50 and 100 mg/Kg for two weeks, caused significant (p < 0.05) reduction in leptin level (
Table 1). Three doses of extract caused significant reduction in the insulin level and liver glycogen content compared to the HS group (
Tables 1 and
2). Muscle glycogen content was significantly decreased in 100 and 200 mg/Kg TP-treated groups in comparison with other groups (
Table 2).
| parameter | Control | HS | HS+50mg/kg | HS+100mg/kg | HS+200mg/kg |
|---|
| Glucose (mg/dL) | 14.102±17.261 b* | 189.983±24.248 ade* | 159.175±23.628 | 148.738±3.808 b* | 121.818±17.078 b* |
| Insulin (μIU/mLl) | 3.120±0.486 b* | 6.888±2.190 acde* | 3.073±0.464 b* | 2.972±0.443 b* | 3.130±0.270 b* |
| Leptin (ng/dL) | 1.133±0.053 | 1.453±0.073 cd* | 1.087±0.131 b* | 1.260±0.247 b* | 1.083±0.247 |
| FIRI | 26.705±3.995 | 34.328±10.445 de* | 23.800±4.400 | 18.652±1.758 b* | 14.310±2.209 b* |
| Total Cholesterol (mg/dL) | 59.705±13.350bcde* | 80.490±15.321acde* | 85.000±10.849ab* | 82.158±8.777ab* | 86.667±18.040ab* |
| Total Lipid (mg/dL) | 608.000±35.355 | 747.000±143.979de* | 773.000±109.545de* | 541.750±75.870bc* | 526.750±109.349bc* |
| Triglyceride (mg/dL) | 64.000±9.977b* | 100.257±17.498ade* | 92.713±11.490de* | 67.897±4.732bc* | 74.920±19.167bc* |
| HDL-cholesterol (mg/dL) | 42.130±7.323 | 36.180±7.346 c* | 53.188±10.089b* | 48.697±4.690 | 45.840±9.749 |
| LDL-cholesterol (mg/dL) | 46.809±7.147 | 40.243±6.186 d* | 34.650±6.795 de* | 60.816±11.378bc* | 52.604±8.910 c* |
| VLDL-cholesterol (mg/dL) | 12.800±1.996bc* | 20.51±3.500ade* | 18.543±2.298ade* | 13.410±0.952bc* | 13.606±2.636bc* |
Glycogen (mg/g of wet tissue)
|
|---|
| Liver | Muscle |
|---|
| Control | 33.546±6.704 b* | 4.113±0.415de* |
| HS | 41.517±3.857 acde* | 4.587±0.140de* |
| HS+50mg/kg | 32.448±5.513 b* | 3.727±0.474de* |
| HS+100mg/kg | 18.902±2.556 b* | 2.545±0.593ab* |
| HS+200mg/kg | 24.087±1.928 b* | 2.810±0.337ab* |
Serum total cholesterol was significantly increased in all experimental groups compared to the control group (p < 0.05). In 100 and 200 mg/Kg groups, there was a significantly decrease in serum TG, VLDL-C and TL compared to 50 mg/Kg and HS groups (p < 0.05). According to the results, TG was significantly increased in HS and 50 mg/Kg groups compared to the control group (p < 0.05). At 100 and 200 mg/Kg doses, there was also significantly decreases in liver TG (p < 0.05) compared to the HS group (
Figure 2). But there was no significant difference in liver and muscle TL between the groups (
Figure 1).
Effect of different doses of Teucrium polium ethyl acetate extract on liver and skeletal muscle lipid content in rats fed by sucrose-rich diet. Each value represents the mean ± SD (n = 6). All values statistically different *p < 0.05
In addition, the muscle TG content was significantly increased in HS, 100 and 200 mg/Kg groups in comparison with the control group (p < 0.05). TP-EAE at a dose of 50 mg caused a significant decrease in muscle TG compared to the HS group (
Figure 2).
Effect of different doses of Teucrium polium ethyl acetate extract on liver and skeletal muscle triglyceride content in rats fed by sucrose-rich diet. Each value represents the mean ± SD (n = 6). All values statistically different *p < 0.05
However, HDL-c level tended to be increased in the TP-treated groups compared to the HS group, the effect of which was significant just at dose of 50 mg/Kg (
Table 1). LDL-c level was significantly increased in 100 mg/Kg group compared to the HS group (p < 0.05), however; there was a significant decrease in 50 mg/Kg group compared to the 100 and 200 mg/Kg groups (
Table 1).
Treating hyperglycemic rats with T.polium extract induced a significant (p < 0.05) dose-dependent reduction in the serum glucose level in comparison with the control animals; but the difference was significant at 100 and 200 mg/Kg groups. Furthermore, a dose-dependent reduction in the serum insulin level as well as liver glycogen content was observed in TP-treated groups. The results show a dose-dependent reduction in the serum level of leptin in TP-treated groups in comparison with HS group, but the difference was significant at 50 and 100 mg/Kg groups. Hypolipidemic activities of T. polium ethyl acetate extract induced a significant (p < 0.05) dose-dependent reduction in the serum and liver lipid content compared to the HS group, but the difference was more significant at 100 and 200 mg/Kg doses.
The increasing of serum glucose and insulin as well as FIRI, is associated with the pre-diabetic and insulin resistance status in the HS group. Numerous studies showed that a high fructose (HF) and/or HS diet induces the insulin resistance in rodents (
31-
32). The pathogenesis of insulin resistance which is caused using a of insulin resistance which is caused using a HF and/or HS is unclear. It was reported that the excessive circulating free fatty acids and glucose may contribute to the insulin resistance (
33 ,
34) .
in addition , in HS diets , the exposure of the liver to large quantities of fructose activate Phosphofructokinase, a hepatic enzyme that governs glycolysis in liver ,negatively regulates the glucose can evade this rate-limiting control mechanism and is metabolized into glycerol-3-phosphate and acetyl-coenzyme A. These two intermediate metabolites that are used as substrates for glyceride synthesis, contribute to the VLDL-c triglyceride production and accumulation in the liver, which in-turn contribute to the reduce insulin sensitivity and hepatic insulin resistance/glucose intolerance (
11,
12).
High-carbohydrate diets may raise triglyceride levels by different mechanisms, such as hepatic overproduction of VLDL-c triglycerides and its secretion into the circulation (35, 36), reduction of lipoprotein lipase activity (
37,
38) or retardation lipolysis of triglyceride-rich lipoproteins (
39).Furthermore, VLDL-c is the precursor to LDL-c and its overproduction may lead to cardiovascular complications (
40,
41). A similar effect was observed in our study; serum VLDL-c level was increased in HS group. On the other hand, TP-EAE was able to produce a dose-dependent reduction in VLDL-c level at 100 and 200 mg/Kg doses. An increase in serum VLDLL-c content elevates the LDL-c level; therefore, carbohydrate-rich diets increase the serum level of LDL-c (
42,
43), but in our study, there was no change in serum LDL-c level. Our results showed that the serum LDL cholesterol level is increased in TP-treated groups (100 and 200 mg/Kg) that is consistent with Shahraki
et al. (2007) reports who demonstrated that serum cholesterol, triglyceride and LDL-c levels were increased through
T. polium aqueous extract in Streptozotocin-induced diabetic male rats (
44).
Moreover, a primary finding indicated that the higher level of liver and muscle TG content in HS group was directly associated with the insulin resistance. In this regard, many evidences suggest that an excess accumulation of hepatic (
3,
4) and skeletal muscle lipid is associated with insulin resistance in human obesity and in type 2 diabetes mellitus (
5,
6) and animal models (
7,
8).Hypotriglyceridemic effect of TP-EAE at the present study is in agreement with Rasaekh
et al. (2001) findings on rat (
21). For the first time, we have shown that hypotriglyceridemic effect of TP-EAE at doses of 100 and 200 mg/ Kg is associated with the reduction in the liver and TG muscle content as well as declination in serum insulin and glucose. Although the lipid-lowering mechanism remain to be understood,
T. polium contains a wide range of active pharmacologic agents including alkaloids, glycosides, terpenoids, sterols, triterpenes, and flavonoids (
45,
46). TP-EAE is a flavonoid-rich extract. Flavonoids may have insulin like and/or insulin-triggering properties have been extracted from the plant. Some kinds of flavonoids may omit the lipid synthesis and secretion from liver (
47). Reduction of TG in liver concurrent with hypotriglyceridemia in TP-treated groups may indicate preventive effect of these flavonoids on liver-TG synthesis and its secretion to blood circulation. Reinner
et al. (1989) investigated the effects of
T. polium fractions on blood cholesterol and TG levels in diabetic male rats and found that the plant has fat-lowering effects by decreasing the blood cholesterol level. Cholesterol lowering effect is largely due to the inhibition of its absorption in small intestine and promoting its hepatic release. The liver plays a critical role in discharging the cholesterol via bile secretion. (
48).
According to Kadifkova
et al. (2007) and Ardestani
et al. (2007) results, ethyl acetate extracts used in this study have hepatoprotective and antioxidant effects (
23,
24) that may protect the liver from the harmful effect of fructose and improve the function of liver.
High sucrose diets increased the serum levels of glucose, insulin as well as liver glycogen content in our work. Glucose transportation and subsequent activation of glycogen synthase are the important steps for controlling the rate of glycogen accumulation in insulin-sensitive tissues such as skeletal muscle (
30,
49). Therefore, observed increase in liver glycogen synthesis in HS group may be explained by the availability and high levels of insulin, even in the face of insulin resistance. Treatment with
T. polium ethyl acetate extract (100 and 200 mg/Kg) for 14 days decreased the muscle and liver glycogen content indicating that the defective glycogen storage of the diabetic rats was partially corrected by the extract. Therefore, it may be concluded that
T. polium increases the glycogenolysis rate by decreasing the hepatic glycogen content or postponing the absorption of blood glucose as a result of blood insulin level decline.
Yazdanparast
et al. (2005) showed that
Teucrium polium extract may reduce the high blood glucose levels through enhancing insulin secretion by the pancreas without significant metabolic changes in Streptozotocin-induced diabetic male rats (
20).
In our study, the amount of leptin was decreased in TP-treated groups. Leptin secretion via adipocytes is stimulated by insulin and the plasma leptin significantly correlates with insulin serum concentrations (
50). Thus, the decreasing effect of
T. polium on plasma insulin level may play a role in leptin reduction.
Leptin has important actions in stimulating the vascular inflammation, oxidative stress, and insulin resistance which may contribute to the pathogenesis of type 2 diabetes mellitus, atherosclerosis, and the coronary heart disease (
51,
52). So, possessing the lowering effects on leptin,
T. polium may improve these conditions.